Skip to main content

Table 1 Demographic, past medical history, and instrumental swallowing assessment (FEES or VFSS) information for patient cohort

From: Injection augmentation and endoscopic repair of type 1 laryngeal clefts: development of a management algorithm

Parameters N of 88 (%)
Median age (range) 18 months (2–99)
Males 54 (61%)
Median follow-up (range) 14 months (4–54)
Comorbidity SDB 22 (25%)
Asthma 4 (5%)
GERD 47 (53%)
Neurological impairment 7 (8%)
Dysmorphism/syndrome 9 (10%)
Ex-prematurity 21 (24%)
None 19 (22%)
Secondary airway lesion Laryngomalacia 2 (2%)
Laryngeal dyskinesia/immobility 3 (3%)
Vocal cord nodules 2 (2%)
TEF 2 (2%)
Tracheomalacia 5 6%)
Presenting symptom Choking (liquids) 60 (68%)
Choking (solids) 33 (38%)
Recurrent pneumonia 42 (48%)
Stridor 28 (32%)
Cyanotic spells 11 (13%)
ALTE 3 (3%)
Instrumental swallowing assessment findings Laryngeal penetration 77 (88%)
Aspiration 37 (42%)
Silent aspiration 34 (39%)